Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

4.12
Delayed Data
As of Dec 08
 +0.06 / +1.48%
Today’s Change
3.05
Today|||52-Week Range
9.72
-31.33%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close4.06
Today’s open4.07
Day’s range3.96 - 4.25
Volume60,550
Average volume (3 months)342,649
Market cap$17.3M
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+27.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...+0.10+3.92%
CBLICleveland Biolabs In...-0.00-0.09%
TNXPTonix Pharmaceutical...+0.05+11.22%
EYEGEyeGate Pharmaceutic...-0.09-5.29%
Data as of 12/08/2016

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts


Search for Jobs